Cavan M. Redmond
President, Pfizer.
Companies
- Insight Molecular Diagnostics Inc.Board member Dec 31, 2015 to Jul 19, 20221
- Lineage Cell TherapeuticsBoard member Apr 27, 2018 to Jul 3, 20182
- PfizerPresident Feb 28, 2011 to Jun 1, 20123
- PfizerSenior Vice President Oct 22, 2009 to Mar 1, 20104
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Pfizer PFE184,840 shares5$5.5M at $29.54Feb 27, 2012- Insight Molecular Diagnostics Inc. IMDX120,863 shares6$356.5K at $2.95Jun 24, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 24, 2022Exercised options 10,000 shares of Insight Molecular Diagnostics Inc.6
- Mar 16, 2022Bought 40,000 shares at $1.19 of Insight Molecular Diagnostics Inc.7
- Feb 23, 2012Granted 21,206 shares of Pfizer5
- Feb 24, 2011Granted 37,851 shares of Pfizer8
- Feb 25, 2010Granted 22,284 shares of Pfizer9
- Oct 30, 2009Granted 17,616 shares of Pfizer10
- Oct 30, 2009Granted 29,360 shares of Pfizer10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARPfizer, President
- 4SEC EDGARPfizer, Senior Vice President
- 5
- 6
- 7SEC EDGARForm 4 filed Mar 16, 2022
- 8SEC EDGARForm 4 filed Feb 28, 2011
- 9SEC EDGARForm 4 filed Mar 1, 2010
- 10SEC EDGARForm 4 filed Nov 3, 2009